J 2025

Comprehensive cost-of-illness analysis of pressure ulcer treatment: A real-world study at a Czech university hospital

KRUPOVA, Lenka; Andrea POKORNÁ; Miroslav KRUPA a Klára BENEŠOVÁ

Základní údaje

Originální název

Comprehensive cost-of-illness analysis of pressure ulcer treatment: A real-world study at a Czech university hospital

Autoři

KRUPOVA, Lenka; Andrea POKORNÁ; Miroslav KRUPA a Klára BENEŠOVÁ

Vydání

International Wound Journal, Hoboken, Wiley-Blackwell, 2025, 1742-4801

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30216 Dermatology and venereal diseases

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.500 v roce 2024

Označené pro přenos do RIV

Ano

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

cost analysis; healthcare costs; patients; pressure ulcers; treatment costs

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 24. 2. 2026 08:51, Mgr. Tereza Miškechová

Anotace

V originále

Pressure ulcers (PUs) impose a significant economic burden on healthcare systems, affecting patient quality of life and leading to substantial treatment costs. This study presents a cost-of-illness analysis of PU treatment in hospitalized patients in the Czech Republic, based on real-world clinical data. The analysis was conducted using a comprehensive methodology at a Czech university hospital, involving 304 hospitalizations. The study included all hospitalized patients with PUs. Data were collected employing a bottom-up, person-based approach, which refers to the collection and analysis of cost data at the individual patient level. This method captures detailed resource utilization for each patient. The methodology accounted for both systemic and local costs, including materials, medications, caregiver time, and procedures. The study involved 304 hospitalizations, with a mean length of stay of 13 days. The total cost of PU treatment, excluding pharmacotherapy, had a median of 678, while including pharmacotherapy, the median cost rose to 929. Younger patients incurred higher treatment costs. Significant cost variations were observed among different departments. We developed and applied a novel cost model to quantify the expenses associated with PUs, which accurately highlighted the financial burden in the hospital care setting. We present a rigorous methodology for PU cost-of-illness analysis, providing a valuable tool for future research and clinical practice. This comprehensive approach supports the development of targeted interventions to reduce the incidence and severity of PUs, ultimately improving patient care and reducing healthcare costs.

Návaznosti

NU20-09-00094, projekt VaV
Název: Analýza nákladovosti léčby dekubitů - determinanty péče (Akronym: CAPUT)
Investor: Ministerstvo zdravotnictví ČR, Analýza nákladovosti léčby dekubitů - determinanty péče, Podprogram 1 - standardní